Consistent with the latter, (Yifeng et al., 2018) used meta-analysis to provide more significant evidence and concluded that CD133 expression along with CD44 is indicative of advanced FIGO level, degree of differentiation, and chemotherapy resistance in ovarian cancer cells. Here, CD44 is linked to ovarian cancer.